National Framework for Genomics in Cancer Control launched

The Australian Government has released Cancer Australia’s National Framework for Genomics in Cancer Control, to guide health professionals, health services, policymakers and researchers in safely and effectively incorporating genomics into cancer care, set out specific goals for the future of genomics-informed cancer care and lay out actions for implementation across the cancer care continuum and the broader health system.

Genomic medicine uses a person’s own DNA to better identify disease risks, prevent illness, make earlier diagnoses and personalise treatment. It is at the cutting edge of medicine and has the potential to deliver vital insights into the way gene mutations drive cancer behaviour. And with the role of genomics in cancer prevention, screening, diagnosis and treatment expanding rapidly, it has broad implications for patient care.

“Australia is at the precipice of transforming the potential of genomics into concrete improvements in cancer care, research, policies and service delivery,” Australia’s Minister for Health and Aged Care Mark Butler said. “Through this Framework, we continue our commitment to providing national leadership in the development and use of genomic medicine, and in delivering world-class outcomes for every Australian affected by cancer.”

Goals within the framework emphasise the need for evidence-based genomic testing — to guide personalised prevention, early detection, diagnosis and treatment. Also highlighted are the importance of building workforce capability in genomics and cultural safety, and in educating and empowering communities to understand the role of genomics in cancer care; best practice cancer care that needs to be underpinned by cancer genomic research, clinical trials and data that accurately represents Australia’s diverse population.

“Some Australians are more at risk of developing cancer than others. Genetic testing can help determine an individual’s risk of certain cancers, and create personalised prevention, risk-reducing and early detection strategies,” Cancer Australia’s Chief Executive Officer Professor Dorothy Keefe said. “For a person diagnosed with cancer, genomics can be used to guide diagnostic and personalised treatment decisions to deliver better outcomes.”

**************************************************

The National Framework for Genomics in Cancer Control was identified as a priority action under the Australian Cancer Plan and provides a policy basis for equitable access to genomic medicine for all Australians affected by cancer. Its development was informed by extensive public consultation, including a focus on Aboriginal and Torres Strait Islander communities, and a rigorous review of national and international evidence. It is available to read at www.canceraustralia.gov.au/key-initiatives/national-framework-genomics-cancer-control.

**************************************************

Image credit: iStock.com/FatCamera